Livagen (20mg)

Livagen – Research Peptide
Livagen is a short bioregulatory peptide that modulates gene expression by directly affecting DNA structure and chromatin organization. Its primary activity is in lymphocytes, with secondary systemic effects observed in the heart, gastrointestinal tract, central nervous system, and immune system. Research indicates that Livagen promotes chromatin decondensation, enhances the expression of select genes, and supports a more youthful cellular profile.

By activating the immune system and influencing gene expression related to cellular health and senescence, Livagen is of interest in studies on anti-aging, immune modulation, and nociception, offering a potential avenue for exploring gene-targeted research in multiple tissues.